Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Investor Expectations to Drive Momentum within Spectrum Pharmaceuticals, Agenus, Williams Companies, Acacia Research, Zebra Technologies, and Diodes — Discovering Underlying Factors of Influence

AGEN, ACTG, DIOD

NEW YORK, Dec. 05, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Agenus Inc. (NASDAQ:AGEN), Williams Companies, Inc. (NYSE:WMB), Acacia Research Corporation (NASDAQ:ACTG), Zebra Technologies Corporation (NASDAQ:ZBRA), and Diodes Incorporated (NASDAQ:DIOD), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

SPPI DOWNLOAD: http://Fundamental-Markets.com/register/?so=SPPI
AGEN DOWNLOAD:
http://Fundamental-Markets.com/register/?so=AGEN
WMB DOWNLOAD:
http://Fundamental-Markets.com/register/?so=WMB
ACTG DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ACTG
ZBRA DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ZBRA
DIOD DOWNLOAD:
http://Fundamental-Markets.com/register/?so=DIOD

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Agenus Inc. (NASDAQ:AGEN), Williams Companies, Inc. (NYSE:WMB), Acacia Research Corporation (NASDAQ:ACTG), Zebra Technologies Corporation (NASDAQ:ZBRA), and Diodes Incorporated (NASDAQ:DIOD) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed December 1st, 2017. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

SPECTRUM PHARMACEUTICALS, INC. (SPPI) REPORT OVERVIEW

Spectrum Pharmaceuticals' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Spectrum Pharmaceuticals reported revenue of $36.40MM vs $33.39MM (up 8.99%) and basic earnings per share -$0.22 vs -$0.22. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Spectrum Pharmaceuticals reported revenue of $146.44MM vs $162.56MM (down 9.91%) and basic earnings per share -$0.94 vs -$0.78. Spectrum Pharmaceuticals is expected to report earnings on March 14th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.22. The estimated EPS forecast for the next fiscal year is -$0.94 and is expected to report on March 14th, 2018.

To read the full Spectrum Pharmaceuticals, Inc. (SPPI) report, download it here: http://Fundamental-Markets.com/register/?so=SPPI

-----------------------------------------

AGENUS INC. (AGEN) REPORT OVERVIEW

Agenus' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Agenus reported revenue of $3.36MM vs $4.45MM (down 24.44%) and basic earnings per share -$0.37 vs -$0.47. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Agenus reported revenue of $22.57MM vs $24.82MM (down 9.04%) and basic earnings per share -$1.46 vs -$1.13. Agenus is expected to report earnings on March 8th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.30. The estimated EPS forecast for the next fiscal year is -$1.38 and is expected to report on March 8th, 2018.

To read the full Agenus Inc. (AGEN) report, download it here: http://Fundamental-Markets.com/register/?so=AGEN

-----------------------------------------

WILLIAMS COMPANIES, INC. (WMB) REPORT OVERVIEW

Williams Companies' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Williams Companies reported revenue of $1,891.00MM vs $1,905.00MM (down 0.73%) and basic earnings per share $0.04 vs $0.08 (down 50.00%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Williams Companies reported revenue of $7,499.00MM vs $7,360.00MM (up 1.89%) and basic earnings per share -$0.57 vs -$0.76. Williams Companies is expected to report earnings on February 21st, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.17. The estimated EPS forecast for the next fiscal year is $0.87 and is expected to report on February 21st, 2018.

To read the full Williams Companies, Inc. (WMB) report, download it here: http://Fundamental-Markets.com/register/?so=WMB

-----------------------------------------

ACACIA RESEARCH CORPORATION (ACTG) REPORT OVERVIEW

Acacia Research's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Acacia Research reported revenue of $36.63MM vs $64.66MM (down 43.34%) and basic earnings per share $3.13 vs $0.14 (up 2,135.71%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Acacia Research reported revenue of $152.70MM vs $125.04MM (up 22.12%) and basic earnings per share -$1.08 vs -$3.25. Acacia Research is expected to report earnings on March 8th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.04. The estimated EPS forecast for the next fiscal year is $0.11 and is expected to report on March 8th, 2018.

To read the full Acacia Research Corporation (ACTG) report, download it here: http://Fundamental-Markets.com/register/?so=ACTG

-----------------------------------------

ZEBRA TECHNOLOGIES CORPORATION (ZBRA) REPORT OVERVIEW

Zebra Technologies' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Zebra Technologies reported revenue of $935.00MM vs $904.00MM (up 3.43%) and basic earnings per share -$0.23 vs -$1.61. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Zebra Technologies reported revenue of $3,574.00MM vs $3,650.00MM (down 2.08%) and basic earnings per share -$2.65 vs -$3.10. Zebra Technologies is expected to report earnings on February 22nd, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $1.82. The estimated EPS forecast for the next fiscal year is $7.35 and is expected to report on February 22nd, 2018.

To read the full Zebra Technologies Corporation (ZBRA) report, download it here: http://Fundamental-Markets.com/register/?so=ZBRA

-----------------------------------------

DIODES INCORPORATED (DIOD) REPORT OVERVIEW

Diodes' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Diodes reported revenue of $285.25MM vs $250.69MM (up 13.78%) and basic earnings per share $0.29 vs $0.22 (up 31.82%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Diodes reported revenue of $942.16MM vs $848.90MM (up 10.99%) and basic earnings per share $0.33 vs $0.50 (down 34.00%). Diodes is expected to report earnings on February 13th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.15. The estimated EPS forecast for the next fiscal year is $1.80 and is expected to report on February 13th, 2018.

To read the full Diodes Incorporated (DIOD) report, download it here: http://Fundamental-Markets.com/register/?so=DIOD

-----------------------------------------

ABOUT Fundamental Markets

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc. 



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today